Free Trial
→ The 401k Email 70 Million Investors Might Delete (From Brownstone Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
$0.16
$0.16
$0.16
▼
$1.57
$763K4.024,068 shsN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$2.75
-0.4%		$3.03
$2.66
▼
$5.49
$46.42M1.1823,653 shs13,208 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
0.00%0.00%0.00%0.00%+13,300.00%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-0.36%-2.48%-7.72%-7.41%-13.79%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
$0.16
$0.16
$0.16
▼
$1.57
$763K4.024,068 shsN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$2.75
-0.4%		$3.03
$2.66
▼
$5.49
$46.42M1.1823,653 shs13,208 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
0.00%0.00%0.00%0.00%+13,300.00%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-0.36%-2.48%-7.72%-7.41%-13.79%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
0.00
N/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
2.60
Moderate Buy$5.83112.12% Upside

Current Analyst Ratings Breakdown

Latest SRTS and ARTH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/18/2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeSell (D) ➝ Sell (D-)
8/17/2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Alliance Global Partners logo
Alliance Global Partners
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingBuy
8/14/2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Lake Street Capital logo
Lake Street Capital
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetBuy$4.50 ➝ $4.00
(Data available from 11/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
$80K9.53N/AN/A($2.43) per share-0.07
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$27.48M1.65N/AN/A$2.93 per share0.94
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
-$6.98M-$2.34N/AN/AN/A-8,257.70%N/A-730.22%N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$7.72M-$0.94N/AN/AN/A-88.45%-21.57%-19.20%11/12/2026 (Estimated)

Latest SRTS and ARTH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/12/2026Q3 2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$0.0550N/AN/AN/A$6.61 millionN/A
8/13/2026Q2 2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$0.1250-$0.53-$0.4050-$0.53$4.60 million$2.29 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
N/A
0.10
0.01
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.71
4.30

Institutional Ownership

CompanyInstitutional Ownership
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
6.91%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
4.50%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
10.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
104.74 million4.53 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
6016.46 million14.78 millionOptionable

Recent News About These Companies

Sensus Healthcare收跌1.77%，成交额4.88万美元
October 29, 2026  |  finance.sina.com.cnF
Sensus Healthcare to Report Third Quarter 2026 Financial Results and Hold Business Update Conference Call on November 12, 2026
October 29, 2026  |  aol.comA
Sensus Healthcare收跌1.06%，成交额16.79万美元
October 29, 2026  |  finance.sina.com.cnF
Sensus Healthcare收涨1.08%，成交额28.2万美元
October 28, 2026  |  finance.sina.com.cnF
Sensus Healthcare收跌4.41%，成交额5.5万美元
October 26, 2026  |  finance.sina.com.cnF
Sensus Healthcare收涨2.79%，成交额3.69万美元
October 24, 2026  |  finance.sina.com.cnF
Sensus Healthcare收涨0.35%，成交额2.98万美元
October 22, 2026  |  finance.sina.com.cnF
Sensus Healthcare收跌0.36%，成交额14.08万美元
October 20, 2026  |  finance.sina.com.cnF
Sensus Healthcare收跌0.36%，成交额6.83万美元
October 19, 2026  |  finance.sina.com.cnF
Sensus Healthcare收平，成交额3.56万美元
October 16, 2026  |  finance.sina.com.cnF
Sensus Healthcare (NASDAQ:SRTS) Director Eric Sachetta Purchases 27,304 Shares of Stock
September 1, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-srts-insider-buying-and-selling-2026-09-01/
Sensus Healthcare Inc
August 31, 2026  |  money.usnews.comhttps://money.usnews.com/investing/stocks/srts-sensus-healthcare-inc/vitals
Insider Buying: Sensus Healthcare (NASDAQ:SRTS) Director Buys $31,939.32 in Stock
August 29, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-srts-insider-buying-and-selling-2026-08-29/
Sensus Healthcare (NASDAQ:SRTS) Director Eric Sachetta Acquires 34,697 Shares
August 26, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-srts-insider-buying-and-selling-2026-08-26/
Sensus (SRTS) Q2 2026 Earnings Call Transcript
August 21, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/sensus-srts-q2-2026-earnings-224513315.html
Sensus outlines shift to $250,000 average selling price as it targets a stronger second half
August 14, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4633003-sensus-outlines-shift-to-250000-average-selling-price-as-it-targets-a-stronger-second-half
Sensus Healthcare, Inc. (SRTS) Q2 2026 Earnings Call Transcript
August 13, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4936537-sensus-healthcare-inc-srts-q2-2026-earnings-call-transcript
Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights
August 13, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260813917539/en/sensus-healthcare-reports-second-quarter-2026-financial-results-and-business-highlights/
Sensus Healthcare to Report Second Quarter 2026 Financial Results and Hold Business Update Conference Call on August 13, 2026
July 30, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260730475712/en/sensus-healthcare-to-report-second-quarter-2026-financial-results-and-hold-business-update-conference-call-on-august-13-2026/
Sensus Healthcare Secures New $15 Million Credit Facility
June 5, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sensus-healthcare-secures-new-15-million-credit-facility?utm_source=marketbeat.com&utm_medium=referral

New MarketBeat Followers Over Time

Media Sentiment Over Time

Arch Therapeutics stock logo

Arch Therapeutics OTCMKTS:ARTH

$0.16 0.00 (0.00%)
As of 10/30/2026

Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. The company's flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. It is also involved in the development of AC5-G for gastrointestinal endoscopic procedures, and AC5-V and AC5 surgical hemostat for hemostasis inside the body. The company was founded in 2006 and is based in Framingham, Massachusetts.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$2.75 -0.01 (-0.36%)
Closing price 11/2/2026 04:00 PM Eastern
Extended Trading
$2.76 +0.02 (+0.55%)
As of 11/2/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas